FUNGIZONE 50MG POWDER FOR STERILE CONCENTRATE

Active substance: AMPHOTERICIN

View full screen / Print PDF » Download PDF ⇩

Transcript
9147A1

FUNGIZONE 50mg
Powder for Sterile Concentrate
Amphotericin B
Please read all of this leaflet carefully before you start taking your
medicine because it contains important information for you.
- Please keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor.
This medicine has been prescribed for you only. Do not pass it on
to others. It may harm them, even if their signs of illness are the
same as yours.
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects not listed in this leaflet.
What is in this leaflet;
1.What Fungizone 50mg Powder for Sterile Concentrate is and what
it is used for
2.What you need to know before being given your medicine
3.How you will be given your medicine
4.Possible Side Effects
5.How to store your medicine
6.Contents of the pack and other information
1.What Fungizone 50mg Powder for Sterile Concentrate is and
what it is used for
The name of your medicine is Fungizone 50mg Powder for Sterile
Concentrate. It contains the active ingredient amphotericin B, which
belongs to a group of medicines called anti-fungal antibiotics.
Fungizone 50mg Powder for Sterile Concentrate is used to treat
serious infections caused by yeasts and certain fungi.
2. What you need to know before being given your medicine
You should not be given this medicine if you:
– are allergic (hypersensitive) to amphotericin or any of the other
ingredients in this medicine.
Take special care with Fungizone 50mg Powder for Sterile
Concentrate if you:
– have any kidney or liver problems
If this applies to you, talk to your doctor before being given Fungizone
50mg Powder for Sterile Concentrate.
Taking other medicines
Always tell your doctor or pharmacist about other medicines you may
be taking or have recently taken including those obtained without a
prescription.
This is especially important if you are taking:
– any anti-cancer medicines (e.g. methotrexate, cyclophosphamide,
cisplatin)
– any medicines which affect your kidney function (e.g. gentamicin,
vancomycin)
– any muscle relaxants (e.g. baclofen, dantrolene, diazepam)
– any corticosteroids (e.g. beclamethasone) or corticotrophins
– any medicines to treat heart failure (e.g. digoxin)
– a medicine called flucytosine used to treat fungal infections
If you have recently had a specific type of transfusion called a
leukocyte transfusion, please tell your doctor.

Pregnancy and breast-feeding
If you are pregnant, think you may be pregnant, or if you are breastfeeding, speak to your doctor before being given Fungizone 50mg
Powder for Sterile Concentrate.
Driving and using machinery
Fungizone 50mg Powder for Sterile Concentrate should not affect your
ability to drive.
Fungizone contains amphotericin B:
This medicinal product also contains less than 1mmol sodium (23mg)
per dose, i.e. essentially ‘sodium- free’.
3. How you will be given your medicine
Fungizone 50mg Powder for Sterile Concentrate will be given to you
in hospital by a doctor or nurse.
The daily dose is 0.25-1.0 mg per kg of your body weight. In some
cases your doctor may consider it necessary to increase this dose to
1.5 mg/kg. If you are given too much of this medicine, you may
experience life-threatening heart or lung problems. If you have any
concerns about the amount of medicine you have been given, please
speak to the person who has given you the infusion for further advice.
It will be given to you slowly through a drip into a vein (an infusion).
This will usually take between 2-4 hours.
A test dose may be given before you start treatment with this
medicine. Several months of treatment is usually necessary to get rid
of the infection completely.
In some patients, the doctor may give other medicines to help reduce
other unwanted effects.
These include:
- medicines to help stop you feeling sick or being sick,
- aspirin,
- an anti-allergy medicine (antihistamine),
- a corticosteroid,
- a medicine to stop your blood from clotting (anticoagulant).
4. Possible side effects
Like all medicines, Fungizone 50mg Powder for Sterile Concentrate
can cause side effects, although not everybody gets them.
Treatment with Fungizone 50mg Powder for Sterile Concentrate may
affect your blood cells, kidneys, liver or heart. For this reason, your
doctor will want to monitor all these things before, during and after
giving you this medicine.
If you notice any of the following, contact your doctor immediately:
– swelling of the face, lips, or tongue
– skin reactions including severe rash and itching
– difficulty breathing
As these may be signs of an allergic reaction.
There have been reports of blood disorders which may be
characterised by fever or chills, sore throat, ulcers in the mouth or
throat, unusual tiredness or weakness, unusual bleeding or
unexplained bruises.
Tell your doctor immediately if you notice any of these symptoms.
Fungizone 50mg Powder for Sterile Concentrate can cause kidney
problems. If you notice that you are more thirsty, need to go to the
toilet more frequently, or the volume of urine increases, tell your doctor
immediately.

PLEASE DETACH BEFORE HANDING ABOVE SECTION TO THE PATIENT

INFORMATION FOR HEALTH PROFESSIONALS
Below is a summary of the dosage, administration, reconstitution and
storage details for Fungizone 50mg Powder for Sterile Concentrate.
Reference should be made to the Summary of Product Characteristics
for full prescribing information.
ADMINISTRATION
Adults and children: Fungizone should be administered by
intravenous infusion over a period of 2-4 hours. Reduction of the
infusion rate may reduce the incidence of side effects. In rare instances
infusion times of up to 6 hours may be necessary. Initial daily dose
should be 0.25 mg/kg of body weight gradually increasing to a level of
1.0 mg/kg of body weight depending on individual response and
tolerance. Within the range of 0.25-1.0 mg/kg the daily dose should be
maintained at the highest level which is not accompanied by
unacceptable toxicity.
In seriously ill patients the daily dose may be gradually increased up
to a total of 1.5 mg/kg. Since amphotericin B is excreted slowly,
therapy may be given on alternate days in patients on the higher
dosage schedule. Several months of therapy are usually necessary; a
shorter period of therapy may produce an inadequate response and
lead to relapse.
When commencing all new courses of treatment, it is advisable to
administer a test dose immediately preceding the first dose. A volume
of the infusion containing 1mg (i.e. 10mL) should be infused over 2030 minutes and the patient carefully observed for at least a further 30
minutes. It should be noted that patient responses to the test dose
may not be predictive of subsequent severe side effects.
Whenever medication is interrupted for a period longer than seven
days, therapy should be resumed by starting with the lowest dosage

level, i.e. 0.25 mg/kg of body weight and increased gradually.
Safety and effectiveness in paediatric patients have not been
established through adequate and well-controlled studies. Systemic
fungal infections have been treated in paediatric patients, with reports
of side effects similar to those seen in adults.
Under no circumstances should a total daily dose of 1.5 mg/kg be
exceeded. The recommended concentration for intravenous infusion
is 10 mg/100 mL.
Elderly: No specific dosage recommendations or precautions.
RECONSTITUTION:
Reconstitute as follows: An initial concentrate of 5 mg amphotericin B
per ml is first prepared by rapidly expressing 10ml sterile water for
injection, without a bacteriostatic agent, directly into the lyophilized
cake, using a sterile needle (minimum diameter: 20 gauge) and syringe.
Shake the vial immediately until the colloidal solution is clear. The
infusion solution, providing 10mg/100mL is obtained by further dilution
(1:50) with 5% Glucose Injection of pH above 4.2. The pH of each
container of Glucose Injection should be ascertained before use.
Commercial Glucose Injection usually has a pH above 4.2; however, if
it is below 4.2 then 1 or 2 ml of buffer should be added to the Glucose
Injection before it is used to dilute a concentrated solution of
amphotericin. The recommended buffer has the following
composition:
Dibasic sodium phosphate (anhydrous) 1.59 g
Monobasic sodium phosphate (anhydrous) 0.96 g
Water for Injections BP q.s. to 100 mL
The buffer should be sterilised before it is added to the Glucose
Injection, either by filtration through a bacterial filter, or by autoclaving
for 30 mins at 15 lb pressure (121°C).

370

Package leaflet: Information for the patient

Patients treated with Fungizone have reported the following side
effects:
Very Common side effects (affects more than 1 user in 10):
• Feeling sick and being sick
• High temperature (sometimes with shaking chills)
• Decrease in potassium in the blood
• Increase in creatine in the blood
• Kidney problems which may lead to abnormal urine production,
kidney stones and imbalances of substances in the blood (e.g.
potassium)
• Difficulty in breathing
• High blood pressure
Common side effects (affects 1 to less than 10 users in 100):
• Anaemia-low level of red blood cells
• Abnormal liver function
• Decreased magnesium in the blood
• Rash
Uncommon side effects (affects 1 to less than 10 users in 1,000):
• Flushing
Other side effects were frequencies are unknown include:
• A rare form of anaemia where there is a low level of red blood cells
• Abnormal blood clotting
• High counts of white blood cells in the blood
• Low counts of white blood cells in the blood
• Low counts of platelets in the blood
• Increased potassium in the blood
• Heart attack
• Irregular heartbeat, sometimes severe
• Hearing loss, ringing in the ears
• Blurred or double vision
• Short-lived spinning sensation (vertigo)
• Stomach cramps, indigestion
• Diarrhoea
• Pain at the injection site, with swollen veins
• Allergic reactions
• Loss of appetite, weight loss
• Pain in muscles and joints
• Convulsions
• Altered mental state
• Inflammation of the lungs; spasm of the lungs and fluid in the lungs
• Itching
• Abnormal kidney function
• Bleeding in intestines, resulting in black faeces
• Rash- characterized by a flat red area on the skin that is covered
with small bumps
• Skin conditions
• Low blood pressure
• Shock

6. Contents of the pack and other information
What Fungizone 50mg Powder for Sterile Concentrate contains
The active substance is amphotericin B. Each vial contains 50mg
(50,000 units) Amphotericin B. The other ingredients are desoxycholic
acid, concentrated phosphoric acid, sodium hydroxide, disodium
phosphate dodecahydrate, monosodium phosphate dehydrate, water.
What Fungizone 50mg Powder for Sterile Concentrate looks like
and contents of the pack
Fungizone 50mg Powder for Sterile Concentrate is a fine yellow to
orange, fluffy powder and is supplied in glass vials.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder:
UK
E.R. Squibb & Sons Limited,
Uxbridge Business Park,
Sanderson Road,
Uxbridge,
Middlesex UB8 1DH,
England.
Tel: 0800 7311736
Ireland
E.R. Squibb & Sons Limited, Bristol-Myers Squibb
Uxbridge Business Park, Pharmaceuticals Limited,
Sanderson Road, Swords,
Uxbridge, County Dublin,
Middlesex UB8 1DH, Ireland.
England. Tel: 1 800 749 749
Manufacturer
Farmar L’Aigle
Usine de Saint-Remy
Rue de I’Isle
28380 Saint-Remy-Sur-Avre
France
This leaflet was last revised in: May 2013

If any of the side effects become serious, or if you notice any side
effects not listed in this leaflet, please tell your doctor.
5. How to store your medicine
Keep this medicine out of the sight and reach of children.
Unopened product will be stored in a refrigerator (2-8°C) in the
pharmacy and should not be used after the expiry date shown on the
carton/label.
This medicine will be prepared in a special area before the doctor or
nurse gives it to you. After being mixed together the medicine will be
kept for no more than 8 hours at room temperature (25°C) or 24 hours
in a refrigerator (2-8°C). It should be stored protected from light.

PLEASE DETACH BEFORE HANDING ABOVE SECTION TO THE PATIENT
CAUTION:
Aseptic technique must be strictly observed in all handling, since no
preservative or bacteriostatic agent is present. Do not reconstitute
with saline solutions.
The use of any diluent other than the ones recommended or the
presence of a bacteriostatic agent in the diluent may cause
precipitation of the amphotericin. Do not use the initial concentrate or
the infusion solution if there is any evidence of precipitation of foreign
matter.
An in-line membrane filter may be used for intravenous infusion of
amphotericin; however the mean pore diameter of the filter should not
be less than 1.0 micron in order to assure passage of the amphotericin
dispersion.
Other preparations for injection should not be added to the infusion
solution or administered via the cannula being used to administer
Fungizone. The use of Fungizone by other routes has been
documented in the published literature:
Bladder irrigation/instillation (eg candiduria): Continuous irrigation
with 50mg Fungizone in 1 litre sterile water each day until urinary
cultures are negative. Intermittent use of volumes of 100-400mL
(concentrations of 37.5-200 mcg/mL) has also been reported. The
urine should be alkalinized (with potassium citrate) and antifungal
ointment applied to the perineal area.
Lung inhalation (eg pulmonary aspergillosis): 8-40 mg amphotericin
B (nebulized in sterile water or 5% Glucose) has been given daily in
divided doses. Concurrent eradication of oral and intestinal yeast
reservoirs is recommended.

Intrathecal (eg coccidiodal meningitis): Patients who do not
respond to fluconazole or itraconazole would be candidates for
intrathecal amphotericin B therapy with or without continuation of
azole treatment. The intrathecal dosage of amphotericin B normally
ranges between 0.1mg and 1.5mg per dose, administered at intervals
ranging from daily to weekly, beginning at a low dosage and increasing
the dosage until the appearance of patient intolerance. Amphotericin
B is irritating when injected into the CSF.
Other: Other uses of solutions prepared using Fungizone include local
instillations for the treatment of fungal infections of the ear, eye,
peritoneum, lung cavities and joint spaces.
SPECIAL PRECAUTIONS FOR STORAGE
Vials of powder for reconstitution should be stored in a refrigerator.
Reconstituted: After reconstitution with 10 mL sterile Water for
Injections the concentrate
(5 mg/ml) should be stored protected from light. Chemical and
physical in-use stability has been demonstrated for 8 hours at up to 25
°C and 24 hours at 2-8 °C.
From a microbiological point of view, due to the absence of any
microbial preservative, the product should be used immediately. If not
used immediately, in-use storage times and conditions prior to use
are the responsibility of the user. These would normally not be longer
than 24 hours at 2-8 °C unless reconstitution has taken place in
controlled and validated aseptic conditions. It is not intended as a
multidose vial. Any unused material should be discarded. Solutions
prepared for intravenous infusion (i.e. 10 mg or less amphotericin per
100 mL) should be used promptly after preparation.
9147A1

BACK

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web4)